These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27374181)

  • 1. Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.
    Niu T; Liu Y; Zhang Y; Fu Q; Liu Z; Wang Z; Fu H; Xu J; Liu K
    Oncotarget; 2016 Aug; 7(31):50017-50026. PubMed ID: 27374181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
    Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
    Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
    Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
    Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.
    NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J
    Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
    Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Long Q; Xu J; Guo J
    Oncotarget; 2016 Sep; 7(39):63661-63668. PubMed ID: 27564117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    Liu Y; Liu H; Liu W; Zhang W; An H; Xu J
    World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
    Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
    Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.
    Qu Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
    Oncotarget; 2016 Dec; 7(51):84775-84784. PubMed ID: 27713173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
    Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
    Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
    Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
    Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
    Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
    Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
    Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
    Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.
    Yang L; Wu Q; Xu L; Zhang W; Zhu Y; Liu H; Xu J; Gu J
    BMC Cancer; 2015 Feb; 15():67. PubMed ID: 25886010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.
    Fu H; Liu Y; Xu L; Chang Y; Zhou L; Zhang W; Yang Y; Xu J
    Medicine (Baltimore); 2016 Apr; 95(17):e3225. PubMed ID: 27124015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
    Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Xu J; Guo J
    BMC Cancer; 2017 Feb; 17(1):117. PubMed ID: 28178948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
    Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
    Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.